Traded Aug 18 · filed 1 day laterNot under a reported trading plan
A Roivant Sciences director sold $1.18M of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director received an award of 775 ROIV shares
Traded Jul 17, 2026 · Filed Jul 22, 2026
- 775
- Shares
Why it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 17, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 22, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-029191
- Filed / recorded